260
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Intensive Dose Ifosfamide and Etoposide with G-CSF for Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma

, , , , , , , , , , , , , , , , , , , , & show all
Pages 317-324 | Received 20 Feb 1999, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chitra Hosing, Rima M. Saliba, Martin Körbling, Sandra Acholonu, John Mcmannis, Paolo Anderlini, Sergio Giralt, Marcos De Lima, Grace-Julia Okoroji, Daniel R. Couriel, Richard Champlin, Issa F. Khouri & Michele L. Donato. (2006) High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma. Leukemia & Lymphoma 47:7, pages 1290-1294.
Read now

Articles from other publishers (12)

Alison M. Gulbis & Whitney D. Wallis. 2024. Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Manual of Hematopoietic Cell Transplantation and Cellular Therapies 125 143 .
Chitra Hosing, Veronica Smith, Beverly Rhodes, Kent Walters, Richmond Thompson, Muzaffar Qazilbash, Issa Khouri, Marcos de Lima, Richard J. Balzer, John McMannis, Richard Champlin, Sergio Giralt & Uday Popat. (2011) Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation. Transfusion 51:6, pages 1300-1313.
Crossref
Chitra Hosing, Rima M. Saliba, Sheena Ahlawat, Martin Körbling, Partow Kebriaei, Amin Alousi, Marcos De Lima, Julia‐Grace Okoroji, John McMannis, Muzaffar Qazilbash, Paolo Anderlini, Sergio Giralt, Richard E. Champlin, Issa Khouri & Uday Popat. (2009) Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. American Journal of Hematology 84:6, pages 335-337.
Crossref
Cara Rosenbaum, David Peace, Elizabeth Rich & Koen Van Besien. (2008) Granulocyte Colony-Stimulating Factor-Based Stem Cell Mobilization in Patients with Sickle Cell Disease. Biology of Blood and Marrow Transplantation 14:6, pages 719-723.
Crossref
Susana Vives, Juan-Manuel Sancho, Jordi Juncà, Joan-Ramon Grifols, Mireia Morgades & Josep-Maria Ribera. (2008) Tratamiento de rescate y movilización de progenitores hematopoyéticos de sangre periférica con altas dosis de ifosfamida y etopósido en pacientes con linfoma. Medicina Clínica 130:5, pages 172-174.
Crossref
Chitra Hosing, Muzaffar H. Qazilbash, Partow Kebriaei, Sergio Giralt, Marilyn S. Davis, Uday Popat, Paolo Anderlini, Elizabeth J. Shpall, John McMannis, Martin Korbling & Richard E. Champlin. (2006) Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma. British Journal of Haematology 133:5, pages 533-537.
Crossref
Yago Nieto. 2005. 163 203 .
Yago Nieto. 2003. 171 209 .
C. Hosing, M. Munsell, S. Yazji, B. Andersson, D. Couriel, M. de Lima, M. Donato, J. Gajewski, S. Giralt, M. Körbling, T. Martin, N.T. Ueno, R.E. Champlin & I.F. Khouri. (2002) Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin’s lymphoma. Annals of Oncology 13:3, pages 450-459.
Crossref
Jan JansenJames M. ThompsonMichael J. DuganPamela NolanMichael C. WiemannRuemu BirhirayP. Jean Henslee‐DowneyLuke P. Akard. (2008) Peripheral Blood Progenitor Cell Transplantation. Therapeutic Apheresis 6:1, pages 5-14.
Crossref
Theresa Hahn, Steven N. Wolff, Myron Czuczman, Richard I. Fisher, Hillard M. Lazarus, Julie Vose, Lisa Warren, Richard Watt & Philip L. McCartbyJr.Jr.. (2001) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: An evidence-based review. Biology of Blood and Marrow Transplantation 7:6, pages 308-331.
Crossref
K van Besien, A Rodriguez, S Tomany, A Younes, M Donato, A Sarris, S Giralt, R Mehra, B Andersson, J Gajewski, R Champlin & F Cabanillas. (2001) Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival. Bone Marrow Transplantation 27:4, pages 397-404.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.